Related references
Note: Only part of the references are listed.Unblinded by the light: amyloid-related imaging abnormalities in Alzheimer's clinical trials
A. Gleason et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease
Adam Southon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective
Paul J. Derry et al.
PROGRESS IN NEUROBIOLOGY (2020)
A resurrection of aducanumab for Alzheimer's disease
Lon Schneider
LANCET NEUROLOGY (2020)
Iron Metabolism, Ferroptosis, and the Links With Alzheimer's Disease
Nao Yan et al.
FRONTIERS IN NEUROSCIENCE (2020)
Identification of the hallmarks of necroptosis and ferroptosis by transmission electron microscopy
Sanae Miyake et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease
Barbara R. Cardoso et al.
NEUROTHERAPEUTICS (2019)
The Effectiveness of Vitamin E Treatment in Alzheimer's Disease
Ana Lloret et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Yanhua Mou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The essential metals for humans: a brief overview
Maria Antonietta Zoroddu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2019)
Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes
Samar S. Khalaf et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer's Disease
Azhaar Ashraf et al.
FRONTIERS IN NEUROSCIENCE (2019)
Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying β-amyloid pathology
Ibrahima Diouf et al.
NEUROBIOLOGY OF DISEASE (2019)
The neuritic plaque in Alzheimer's disease: perivascular degeneration of neuronal processes
Gurpreet Kaur Hansra et al.
NEUROBIOLOGY OF AGING (2019)
Microglia and the aging brain: are senescent microglia the key to neurodegeneration?
Dafina M. Angelova et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Clinical utility of serum hepcidin and iron profile measurements in Alzheimer's disease
Oh Joo Kweon et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
The neuropathological diagnosis of Alzheimer's disease
Michael A. DeTure et al.
MOLECULAR NEURODEGENERATION (2019)
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Leda Mezzaroba et al.
NEUROTOXICOLOGY (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease
Changjun Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Redox active metals in neurodegenerative diseases
Karla Acevedo et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2019)
On the role of synthesized hydroxylated chalcones as dual functional amyloid-β aggregation and ferroptosis inhibitors for potential treatment of Alzheimer's disease
Lin Cong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation
Tee Jong Huat et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Emma Nichols et al.
LANCET NEUROLOGY (2019)
A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases
Yash Pal Singh et al.
MOLECULAR DIVERSITY (2019)
Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease
Yorley Duarte et al.
CHEMISTRYSELECT (2019)
Does iron loading of oxygen-sensing prolyl hydroxylases rather than random Fenton-driven radical formation drive programmed ferroptosis and degeneration in neurological diseases?
Rajiv R. Ratan
CURRENT OPINION IN PHYSIOLOGY (2019)
Dual-target anti-Alzheimer's disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity
Zhisheng Mi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Evidence that iron accelerates Alzheimer's pathology: a CSF biomarker study
Scott Ayton et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load
K. Goozee et al.
MOLECULAR PSYCHIATRY (2018)
Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease
Lei Du et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Novel chelators based on adamantane-derived semicarbazones and hydrazones that target multiple hallmarks of Alzheimer's disease
Duraippandi Palanimuthu et al.
DALTON TRANSACTIONS (2018)
Metallomics for Alzheimer's disease treatment: Use of new generation of chelators combining metal-cation binding and transport properties
Cosimo Walter D'Acunto et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Metals and Alzheimer's Disease: How Far Have We Come in the Clinic?
Paul A. Adlard et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Fe(II) formation after interaction of the amyloid β-peptide with iron-storage protein ferritin
Lucia Balejcikova et al.
JOURNAL OF BIOLOGICAL PHYSICS (2018)
Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer's disease therapy
Asha Hiremathad et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and beta-amyloid as an indicator of cognitive performance at high age
J. M. G. van Bergen et al.
NEUROIMAGE (2018)
Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
Moataz Abdalkader et al.
FRONTIERS IN NEUROSCIENCE (2018)
Oxidative stress and the amyloid beta peptide in Alzheimer's disease
C. Cheignon et al.
REDOX BIOLOGY (2018)
Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties
Pei Cai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Postmortem T2* - Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease
Marjolein Bulk et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Ferritinophagy/ferroptosis: Iron-related newcomers in human diseases
Mingzhu Tang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug
Karam Chand et al.
METALLOMICS (2018)
Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice
Abdel A. Belaidi et al.
NEUROTHERAPEUTICS (2018)
Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
Shalini S. Rao et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer's Disease
Amanda L. Lumsden et al.
FRONTIERS IN NEUROSCIENCE (2018)
Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications
Jun-Lin Liu et al.
FRONTIERS IN NEUROSCIENCE (2018)
Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
Moussa B. H. Youdim
JOURNAL OF NEURAL TRANSMISSION (2018)
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease
Jayasankar Kosaraju et al.
MOLECULAR NEUROBIOLOGY (2017)
A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease
Duraippandi Palanimuthu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment
Lili Gao et al.
MOLECULAR MEDICINE REPORTS (2017)
The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models
Tamar Amit et al.
NEUROPHARMACOLOGY (2017)
Application of quinazoline and pyrido[3,2-d]pyrimidine templates to design multi-targeting agents in Alzheimer's disease
Tarek Mohamed et al.
RSC ADVANCES (2017)
Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration
William Sealy Hambright et al.
REDOX BIOLOGY (2017)
Three-Dimensional Tomographic Imaging and Characterization of Iron Compounds within Alzheimer's Plaque Core Material
Joanna F. Collingwood et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice
Yun Zhang et al.
BRAIN RESEARCH (2017)
Iron Biochemistry is Correlated with Amyloid Plaque Morphology in an Established Mouse Model of Alzheimer's Disease
Neil D. Telling et al.
CELL CHEMICAL BIOLOGY (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline
Scott Ayton et al.
BRAIN (2017)
Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron
Foozhan Tahmasebinia et al.
BIOMETALS (2017)
12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice
Antonio Di Meco et al.
BIOLOGICAL PSYCHIATRY (2017)
Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease
Rong Sheng et al.
ACS CHEMICAL NEUROSCIENCE (2016)
The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease
Xun-Hu Gu et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease
Flavio A. R. Barbosa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging
Yeonsil Moon et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Tacrine-(hydroxybenzoyl-pyridone) hybrids as potential multifunctional anti-Alzheimer's agents: AChE inhibition, antioxidant activity and metal chelating capacity
Karam Chand et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Prochelator strategies for site-selective activation of metal chelators
Valentina Oliveri et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Abdel A. Belaidi et al.
JOURNAL OF NEUROCHEMISTRY (2016)
In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan
Julio Acosta-Cabronero et al.
JOURNAL OF NEUROSCIENCE (2016)
Iron chelation in the treatment of neurodegenerative diseases
Petr Dusek et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2016)
Fe2+ binding on amyloid -peptide promotes aggregation
Subramaniam Boopathi et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2016)
The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease
Priyanjalee Banerjee et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer's disease
Shishun Xie et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Amyloid β25-35 induced ROS-burst through NADPH oxidase is sensitive to iron chelation in microglial Bv2 cells
Kristin Part et al.
BRAIN RESEARCH (2015)
DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
Edy Kornelius et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Parkinson's Disease Iron Deposition Caused by Nitric Oxide-Induced Loss of β-Amyloid Precursor Protein
Scott Ayton et al.
JOURNAL OF NEUROSCIENCE (2015)
Neurodegenerative diseases and therapeutic strategies using iron chelators
Roberta J. Ward et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2015)
Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice
J. Chu et al.
MOLECULAR PSYCHIATRY (2015)
7T T2*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease
Sanneke van Rooden et al.
NEUROBIOLOGY OF AGING (2015)
R2*mapping for brain iron: associations with cognition in normal aging
Christine Ghadery et al.
NEUROBIOLOGY OF AGING (2015)
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
Sebastian Palmqvist et al.
NEUROLOGY (2015)
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE
Scott Ayton et al.
NATURE COMMUNICATIONS (2015)
Biometals and Their Therapeutic Implications in Alzheimer's Disease
Scott Ayton et al.
NEUROTHERAPEUTICS (2015)
Deferiprone in Friedreich Ataxia: A 6-Month Randomized Controlled Trial
Massimo Pandolfo et al.
ANNALS OF NEUROLOGY (2014)
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
David Devos et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
HERC2 Targets the Iron Regulator FBXL5 for Degradation and Modulates Iron Metabolism
Toshiro Moroishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Jose Pedro Friedmann Angeli et al.
NATURE CELL BIOLOGY (2014)
Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice
Antonio Di Meco et al.
NEUROBIOLOGY OF AGING (2014)
The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The interplay between iron accumulation, maochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders
Pamela J. Urrutia et al.
FRONTIERS IN PHARMACOLOGY (2014)
Multifunctional iron- chelators with protective roles against neurodegenerative diseases
Andreia Nunes et al.
DALTON TRANSACTIONS (2013)
Increased Iron Levels and Decreased Tissue Integrity in Hippocampus of Alzheimer's Disease Detected in vivo with Magnetic Resonance Imaging
Erika P. Raven et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse model
She-Qing Zhang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
Jayasankar Kosaraju et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Enhanced Brain Delivery of Deferasirox-Lactoferrin Conjugates for Iron Chelation Therapy in Neurodegenerative Disorders: In Vitro and in Vivo Studies
Golnaz Kamalinia et al.
MOLECULAR PHARMACEUTICS (2013)
Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
Chuang Guo et al.
NEUROBIOLOGY OF AGING (2013)
Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain
Chuang Guo et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Ferritin light chain interacts with PEN-2 and affects γ-secretase activity
Xinxin Li et al.
NEUROSCIENCE LETTERS (2013)
Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a Mouse Model of Alzheimer's Disease with Plaques and Tangles
Jin Chu et al.
PLOS ONE (2013)
The Correlation of Hippocampal T2-Mapping with Neuropsychology Test in Patients with Alzheimer's Disease
Zhuren Luo et al.
PLOS ONE (2013)
Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
S. M. Mills et al.
REVUE NEUROLOGIQUE (2013)
The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease
Animesh Alexander Raha et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
The Novel Multi-Target Iron Chelating-Radical Scavenging Compound M30 Possesses Beneficial Effects on Major Hallmarks of Alzheimer's Disease
Lana Kupershmidt et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Deferiprone Reduces Amyloid-β and Tau Phosphorylation Levels but not Reactive Oxygen Species Generation in Hippocampus of Rabbits Fed a Cholesterol-Enriched Diet
Jaya R. P. Prasanthi et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice
Leah R. Hanson et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2012)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease
Alessandra Gaeta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Asymptomatic Alzheimer's Disease: A Prodrome or a State of Resilience?
I. Driscoll et al.
CURRENT ALZHEIMER RESEARCH (2011)
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation
Giovanni Abbruzzese et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Iron(II) Binding to Amyloid-β, the Alzheimer's Peptide
Fatima Bousejra-ElGarah et al.
INORGANIC CHEMISTRY (2011)
Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation
Beinan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain
Mark A. Lovell et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2011)
Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease
P. A. Yates et al.
NEUROLOGY (2011)
Selective Acetylcholinesterase Inhibitor Activated by Acetylcholinesterase Releases an Active Chelator with Neurorescuing and Anti-Amyloid Activities
Hailin Zheng et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Lipid Oxidation and Peroxidation in CNS Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities
Rao Muralikrishna Adibhatla et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Iron in neuronal function and dysfunction
Gabriela A. Salvador
BIOFACTORS (2010)
Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease
James A. Duce et al.
CELL (2010)
Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders
Eric Mills et al.
FUTURE MEDICINAL CHEMISTRY (2010)
Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment
Mark A. Smith et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Selective Translational Control of the Alzheimer Amyloid Precursor Protein Transcript by Iron Regulatory Protein-1
Hyun-Hee Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Ternary Complexes of Iron, Amyloid-β, and Nitrilotriacetic Acid: Binding Affinities, Redox Properties, and Relevance to Iron-Induced Oxidative Stress in Alzheimer's Disease
Dianlu Jiang et al.
BIOCHEMISTRY (2009)
Variable-field relaxometry of iron-containing human tissues: a preliminary study
Aline Hocq et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2009)
Fenton chemistry and oxidative stress mediate the toxicity of the β-amyloid peptide in a Drosophila model of Alzheimer's disease
Thomas Rival et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease
Muralidhar L. Hegde et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
MRI and Histological Analysis of Beta-Amyloid Plaques in Both Human Alzheimer's Disease and APP/PS1 Transgenic Mice
Mark D. Meadowcroft et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
Routes to 4-hydroxynonenal: Fundamental issues in the mechanisms of lipid peroxidation
Claus Schneider et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Oxidative stress and covalent modification of protein with bioactive aldehydes
Paul A. Grimsrud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells
Francisco Molina-Holgado et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Selective intracellular release of copper and zinc ions from bis( thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-β peptide
Paul S. Donnelly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications
Yang-Sung Sohn et al.
BLOOD (2008)
Selective iron chelation in Friedreich ataxia:: biologic and clinical implications
Nathalie Boddaert et al.
BLOOD (2007)
Iron chelation in the biological activity of curcumin
Y Jiao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Protein carbonylation, cellular dysfunction, and disease progression
Isabella Dalle-Donne et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Protein adducts generated from products of lipid oxidation: Focus on HNE and ONE
Lawrence M. Sayre et al.
DRUG METABOLISM REVIEWS (2006)
The evolution of iron chelators for the treatment of iron overload disease and cancer
DS Kalinowski et al.
PHARMACOLOGICAL REVIEWS (2005)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Aβ peptides
XD Huang et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2004)
Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity
F Kuperstein et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Protein carbonylation in human diseases
I Dalle-Donne et al.
TRENDS IN MOLECULAR MEDICINE (2003)
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease - A pilot phase 2 clinical trial
CW Ritchie et al.
ARCHIVES OF NEUROLOGY (2003)
An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript
JT Rogers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Lipid peroxidation and protein oxidation in Alzheimer's disease brain:: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress
DA Butterfield et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Brain iron metabolism and neurodegenerative disorders
JC Sipe et al.
DEVELOPMENTAL NEUROSCIENCE (2002)
Systemic iron metabolism: A review and implications for brain iron metabolism
TA Rouault
PEDIATRIC NEUROLOGY (2001)
Iron and iron management proteins in neurobiology
JR Connor et al.
PEDIATRIC NEUROLOGY (2001)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water
TP Flaten
BRAIN RESEARCH BULLETIN (2001)
Redox-active iron mediates amyloid-β toxicity
CA Rottkamp et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome
CJ Earley et al.
NEUROLOGY (2000)
In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging
G Bartzokis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals
LM Sayre et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
